A.R.T. Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-30,700
Closed -$2.83M 1803
2018
Q3
$2.83M Buy
30,700
+25,700
+514% +$2.45M 0.13% 211
2018
Q2
$491K Buy
+5,000
New +$559K 0.02% 929
2016
Q3
Sell
-14,987
Closed -$1.03M 1335
2016
Q2
$1.03M Buy
14,987
+5,400
+56% +$372K 0.05% 538
2016
Q1
$684K Buy
9,587
+1,800
+23% +$113K 0.03% 741
2015
Q4
$483K Buy
+7,787
New +$475K 0.02% 878

Other funds holding CMD

A.R.T. Advisors's CMD Position: Q4 2018 in Review

A.R.T. Advisors sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 30,700 shares — an estimated $2.83M sold.

A.R.T. Advisors first reported a position in CMD in Q4 2015 and held it in 5 quarters. The position peaked at $2.83M in Q3 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • A.R.T. Advisors reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 30,700 Cantel Medical Corporation shares in Q4 2018, an estimated $2.83M.
  • A.R.T. Advisors first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 5 quarters.
  • A.R.T. Advisors's Cantel Medical Corporation position peaked at $2.83M in Q3 2018.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.